Skip to main content


Zantac sales halted by Walgreens and CVS over carcinogen fears

By The New York Times  
   September 30, 2019

The pharmacy chains pulled the heartburn medication from shelves after the Food and Drug Administration warned that it had detected low levels of a cancer-causing chemical in samples of the drug.

Full story

Get the latest on healthcare leadership in your inbox.